These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 33851424)

  • 21. Serum concentrations of sertraline and N-desmethyl sertraline in relation to CYP2C19 genotype in psychiatric patients.
    Rudberg I; Hermann M; Refsum H; Molden E
    Eur J Clin Pharmacol; 2008 Dec; 64(12):1181-8. PubMed ID: 18677622
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Modelling Age-Related Changes in the Pharmacokinetics of Risperidone and 9-Hydroxyrisperidone in Different CYP2D6 Phenotypes Using a Physiologically Based Pharmacokinetic Approach.
    Kneller LA; Hempel G
    Pharm Res; 2020 May; 37(6):110. PubMed ID: 32476097
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impact of the novel CYP2C:TG haplotype and CYP2B6 variants on sertraline exposure in a large patient population.
    Bråten LS; Ingelman-Sundberg M; Jukic MM; Molden E; Kringen MK
    Clin Transl Sci; 2022 Sep; 15(9):2135-2145. PubMed ID: 35668575
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A poor metabolizer for cytochromes P450 2D6 and 2C19: a case report on antidepressant treatment.
    Johnson M; Markham-Abedi C; Susce MT; Murray-Carmichael E; McCollum S; de Leon J
    CNS Spectr; 2006 Oct; 11(10):757-60. PubMed ID: 17008819
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of Omeprazole Limited Sampling Strategies to Estimate Constitutive Cytochrome P450 2C19 Activity in Healthy Adults.
    Lin S; Nikanjam M; Capparelli EV; Allegrini A; Pavone D; Yim DS; Hammami MM; Bertino JS; Nafziger AN; Park YS; Kang JS; Yin OQ; Ma JD
    Ther Drug Monit; 2018 Dec; 40(6):754-758. PubMed ID: 30045358
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sex differences in the impact of CYP2C19 polymorphisms and low-grade inflammation on coronary microvascular disorder.
    Akasaka T; Hokimoto S; Sueta D; Tabata N; Sakamoto K; Yamamoto E; Yamamuro M; Tsujita K; Kojima S; Kaikita K; Kajiwara A; Morita K; Oniki K; Saruwatari J; Nakagawa K; Ogata Y; Ogawa H
    Am J Physiol Heart Circ Physiol; 2016 Jun; 310(11):H1494-500. PubMed ID: 26993229
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [The polymorphism of cytochrome P(450) 2C19 gene in patients with invasive fungal infections.].
    Wu JQ; Zhu LP; Ou XT; Xu B; Zhang QQ; Weng XH
    Zhonghua Nei Ke Za Zhi; 2010 Feb; 49(2):138-41. PubMed ID: 20356512
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Changes in Sertraline Plasma Concentrations Across Pregnancy and Postpartum.
    Stika CS; Wisner KL; George AL; Avram MJ; Zumpf K; Rasmussen-Torvik LJ; Mesches GA; Caritis SN; Venkataramanan R; Costantine MM; West HA; Clark S; Ciolino JD
    Clin Pharmacol Ther; 2022 Dec; 112(6):1280-1290. PubMed ID: 36094046
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A Randomized Study of the Safety, Tolerability, Pharmacodynamics, and Pharmacokinetics of Clopidogrel in Three Different CYP2C19 Genotype Groups of Healthy Japanese Subjects.
    Kobayashi M; Kajiwara M; Hasegawa S
    J Atheroscler Thromb; 2015; 22(11):1186-96. PubMed ID: 26063503
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Notable Drug-Drug Interaction Between Etizolam and Itraconazole in Poor Metabolizers of Cytochrome P450 2C19.
    Yamamoto T; Furihata K; Hisaka A; Moritoyo T; Ogoe K; Kusayama S; Motohashi K; Mori A; Iwatsubo T; Suzuki H
    J Clin Pharmacol; 2017 Nov; 57(11):1491-1499. PubMed ID: 28679023
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical validity: Combinatorial pharmacogenomics predicts antidepressant responses and healthcare utilizations better than single gene phenotypes.
    Altar CA; Carhart JM; Allen JD; Hall-Flavin DK; Dechairo BM; Winner JG
    Pharmacogenomics J; 2015 Oct; 15(5):443-51. PubMed ID: 25686762
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Expansion of a PBPK model to predict disposition in pregnant women of drugs cleared via multiple CYP enzymes, including CYP2B6, CYP2C9 and CYP2C19.
    Ke AB; Nallani SC; Zhao P; Rostami-Hodjegan A; Unadkat JD
    Br J Clin Pharmacol; 2014 Mar; 77(3):554-70. PubMed ID: 23834474
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Association of CYP2C19 polymorphisms and lansoprazole-associated respiratory adverse effects in children.
    Lima JJ; Lang JE; Mougey EB; Blake KB; Gong Y; Holbrook JT; Wise RA; Teague WG
    J Pediatr; 2013 Sep; 163(3):686-91. PubMed ID: 23623526
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CYP2C19 Genotype-Dependent Pharmacokinetic Drug Interaction Between Voriconazole and Ritonavir-Boosted Atazanavir in Healthy Subjects.
    Zhu L; Brüggemann RJ; Uy J; Colbers A; Hruska MW; Chung E; Sims K; Vakkalagadda B; Xu X; van Schaik RH; Burger DM; Bertz RJ
    J Clin Pharmacol; 2017 Feb; 57(2):235-246. PubMed ID: 27432796
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Phenotypic Assessment of Drug Metabolic Pathways and P-Glycoprotein in Patients Treated With Antidepressants in an Ambulatory Setting.
    Lloret-Linares C; Bosilkovska M; Daali Y; Gex-Fabry M; Heron K; Bancila V; Michalopoulos G; Perroud N; Richard-Lepouriel H; Aubry JM; Desmeules J; Besson M
    J Clin Psychiatry; 2018; 79(2):. PubMed ID: 29570971
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of Routine Cytochrome P450 2D6 and 2C19 Genotyping on Antipsychotic Drug Persistence in Patients With Schizophrenia: A Randomized Clinical Trial.
    Jürgens G; Andersen SE; Rasmussen HB; Werge T; Jensen HD; Kaas-Hansen BS; Nordentoft M
    JAMA Netw Open; 2020 Dec; 3(12):e2027909. PubMed ID: 33284338
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Placental passage of antidepressant medications.
    Hendrick V; Stowe ZN; Altshuler LL; Hwang S; Lee E; Haynes D
    Am J Psychiatry; 2003 May; 160(5):993-6. PubMed ID: 12727706
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Potent cytochrome P450 2C19 genotype-related interaction between voriconazole and the cytochrome P450 3A4 inhibitor ritonavir.
    Mikus G; Schöwel V; Drzewinska M; Rengelshausen J; Ding R; Riedel KD; Burhenne J; Weiss J; Thomsen T; Haefeli WE
    Clin Pharmacol Ther; 2006 Aug; 80(2):126-35. PubMed ID: 16890574
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Influence of Combined CYP2D6 and CYP2C19 Genotypes on Venlafaxine and O-Desmethylvenlafaxine Concentrations in a Large Patient Cohort.
    Kringen MK; Bråten LS; Haslemo T; Molden E
    J Clin Psychopharmacol; 2020; 40(2):137-144. PubMed ID: 32134850
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Population pharmacokinetic modeling of sertraline treatment in patients with Alzheimer disease: the DIADS-2 study.
    Li CH; Pollock BG; Lyketsos CG; Vaidya V; Drye LT; Kirshner M; Sorisio D; Bies RR;
    J Clin Pharmacol; 2013 Feb; 53(2):234-9. PubMed ID: 23436269
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.